Effects of Neutralization by Soluble ABH Antigens Produced by Transplanted Kidneys From ABO-Incompatible Secretor Donors
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Grafts survive despite blood group antigens on the transplant being continuously exposed to antibodies in the blood of recipients in ABO-incompatible kidney transplantation (ABOi KT), owing to the mechanism of accommodation. We analyzed the immunodynamics of soluble ABH antigens in allografts from secretor donors and the influence of such immunodynamics on accommodation and subsequent graft survival in ABOi KT. Methods: The genotype of a known human β-galactoside α-1,2-fucosyltransferase gene (FUT2), which determines soluble ABH antigen secretor status, was established in 32 donors for ABOi KT at the Severance Hospital, from June 2010 to July 2015. Clinical outcomes of recipients, such as anti-A/B antibody titer change, renal function, and graft survival, were evaluated. Results: Twenty-five donors were secretors (78.1%), and seven were nonsecretors (21.9%). The frequency of anti-A/B IgG or IgM antibody titer elevation or reduction post-transplantation was not significantly related to donor secretor status. However, IgM titer was rapidly reduced in recipients transplanted from nonsecretor donors (P=0.01), which could be explained by the lack of absorption effect of soluble antigens, enhancing the binding of antibodies to antigens in the allografts. Interestingly, soluble ABH antigens did not affect rejection-free graft survival, which may be due to the nature of β-galactoside α-1,2-fucosyltransferase. Conclusions: Soluble ABH antigens produced by transplanted kidneys from secretor donors played a role in inducing accommodation within three months of KT through neutralization; however, major graft outcomes were not affected.
Abstract
Background: Grafts survive despite blood group antigens on the transplant being continuously exposed to antibodies in the blood of recipients in ABO-incompatible kidney transplantation (ABOi KT), owing to the mechanism of accommodation. We analyzed the immunodynamics of soluble ABH antigens in allografts from secretor donors and the influence of such immunodynamics on accommodation and subsequent graft survival in ABOi KT. Methods: The genotype of a known human β-galactoside α-1,2-fucosyltransferase gene (FUT2), which determines soluble ABH antigen secretor status, was established in 32 donors for ABOi KT at the Severance Hospital, from June 2010 to July 2015. Clinical outcomes of recipients, such as anti-A/B antibody titer change, renal function, and graft survival, were evaluated. Results: Twenty-five donors were secretors (78.1%), and seven were nonsecretors (21.9%). The frequency of anti-A/B IgG or IgM antibody titer elevation or reduction post-transplantation was not significantly related to donor secretor status. However, IgM titer was rapidly reduced in recipients transplanted from nonsecretor donors (P=0.01), which could be explained by the lack of absorption effect of soluble antigens, enhancing the binding of antibodies to antigens in the allografts. Interestingly, soluble ABH antigens did not affect rejection-free graft survival, which may be due to the nature of β-galactoside α-1,2-fucosyltransferase. Conclusions: Soluble ABH antigens produced by transplanted kidneys from secretor donors played a role in inducing accommodation within three months of KT through neutralization; however, major graft outcomes were not affected.
참고문헌 (32)
- Nelson PW, "Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system?", Am J Transplant, 2, pp.94~99 (2002)
- Porter KA, "Morphological aspects of renal homograft rejection", Br Med Bull, 21, pp.171~175 (1965)
- Soohun Yoo, "Role of Plasma Exchange in ABO-incompatible Kidney Transplantation", Annals of Laboratory Medicine, 32(4), pp.283~288 (2012), 대한진단검사의학회
- Cosio FG, "Significance and implications of capillaritis during acute rejection of kidney allografts", Transplantation, 89, pp.1088~1094 (2010)
- Tantravahi J, "Why hasn’t eliminating acute rejection improved graft survival?", Annu Rev Med, 58, pp.369~385 (2007)
- Ravn V, "Tissue distribution of histo-blood group antigens", APMIS, 108, pp.1~28 (2000)
- Oriol R, "Biosynthesis of ABH and Lewis antigens in normal and transplanted kidneys", Transplantation, 29, pp.184~188 (1980)
- Ulfvin A, "Expression of glycolipid blood group antigens in single human kidneys: change in antigen expression of rejected ABO incompatible kidney grafts", Kidney Int, 44, pp.1289~1297 (1993)
- Kumazaki T, "Biochemical evidence that secretor gene, Se, is a structural gene encoding a specific fucosyltransferase", Proc Natl Acad Sci USA, 81, pp.4193~4197 (1984)
- Sarnesto A, "Purification of the β-N-acetylglucosaminide α 1→3-fucosyltransferase from human serum", J Biol Chem, 267, pp.2745~2752 (1992)
- Wilbrandt R, "ABO blood group incompatibility in human renal homotransplantation", Am J Clin Pathol, 51, pp.15~23 (1969)
- Montgomery RA, "Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols", Transplantation, 78, pp.181~185 (2004)
- Park WD, "Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury", Am J Transplant, 3, pp.952~960 (2003)
- Takahashi K, "Accommodation in ABO-incompatible kidney transplantation: why do kidney grafts survive?", Transplant Proc, 36(S2), pp.S193~S196 (2004)
- Tang AH, "Accommodation of grafts: implications for health and disease", Hum Immunol, 68, pp.645~651 (2007)
- Park KU, "The fusion allele of the FUT2 (secretor type α(1,2)-fucosyltransferase) gene at a high frequency and a new se385 allele in a Korean population", Ann Hematol, 84, pp.656~660 (2005)
- Fung MK, "Technical manual" (2014), American Association of Blood Banks
- Mengel M, "Banff 2011 Meeting report: new concepts in antibody-mediated rejection", Am J Transplant, 12, pp.563~570 (2012)
- Lakkis FG, "Immunologic ‘ignorance’ of vascularized organ transplants in the absence of secondary lymphoid tissue", Nat Med, 6, pp.686~688 (2000)
- Lynch RJ, "Accommodation in renal transplantation: unanswered questions", Curr Opin Organ Transplant, 15, pp.481~485 (2010)
- Platt JL, "Transplantation of discordant xenografts: a review of progress", Immunol Today, 11, pp.450~456 (1990)
- Rydberg L, "ABO-incompatibility in solid organ transplantation", Transfus Med, 11, pp.325~342 (2001)
- Costa C, "Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection", Xenotransplantation, 9, pp.45~57 (2002)
- Tabata T, "Accommodation after lung xenografting from hamster to rat", Transplantation, 75, pp.607~612 (2003)
- Kudo T, "Molecular genetic analysis of the human Lewis histo-blood group system. II. Secretor gene inactivation by a novel single missense mutation A385T in Japanese nonsecretor individuals", J Biol Chem, 271, pp.9830~9837 (1996)
- Moon CK, "Lewis phenotypes and ABH secretor status of Korean adults", Korean J Clin Pathol, 4, pp.237~244 (1984)
- Suh IB, "The genotyping of the secretory gene (Sec2) in the Korean population", Korean J Clin Pathol, 19, pp.572~577 (1999)
- Stussi G, "Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method", Br J Haematol, 130, pp.954~963 (2005)
- Halloran PF, "Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies", Kidney Int, 85, pp.258~264 (2014)
- Yoshida A, "Plasma blood group glycosyltransferase activities after bone marrow transplantation", Blood, 55, pp.699~701 (1980)
- Takahashi K, "A new concept of accommodation in ABO-incompatible kidney transplantation", Clin Transplant, 19(S14), pp.S76~S85 (2005)
- Won DI, "Flow cytometry antibody screening using pooled red cells", Cytometry B Clin Cytom, 78, pp.96~104 (2010)